Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The NLRP3 inflammasome and diabetic cardiomyopathy : editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al.

× No keyword cloud information.

12 in total

Review 1. Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Authors: Sumit Kar; Tyler N Kambis; Paras K Mishra
Journal: Am J Physiol Heart Circ Physiol Date: 2019-03-29 Impact factor: 4.733

Review 2. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

Authors: Abdullah Kaplan; Emna Abidi; Ahmed El-Yazbi; Ali Eid; George W Booz; Fouad A Zouein
Journal: Heart Fail Rev Date: 2018-05 Impact factor: 4.214

3. NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression.

Authors: Fangfang Li; Hao Zhang; Lu Yang; Hui Yong; Qingqing Qin; Mengtong Tan; Luhong Xu; Kai Liang; Jing Zong; Wenhao Qian
Journal: J Mol Med (Berl) Date: 2018-08-29 Impact factor: 4.599

Review 4. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Authors: Christopher J Nolan; Neil B Ruderman; Steven E Kahn; Oluf Pedersen; Marc Prentki
Journal: Diabetes Date: 2015-03 Impact factor: 9.461

Review 5. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.

Authors: Beibei Luo; Feng Huang; Yanli Liu; Yiying Liang; Zhe Wei; Honghong Ke; Zhiyu Zeng; Weiqiang Huang; Yan He
Journal: Front Physiol Date: 2017-07-25 Impact factor: 4.566

Review 6. Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.

Authors: Arpeeta Sharma; Mitchel Tate; Geetha Mathew; James E Vince; Rebecca H Ritchie; Judy B de Haan
Journal: Front Physiol Date: 2018-02-20 Impact factor: 4.566

The NLRP3 inflammasome and diabetic cardiomyopathy : editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al.

Review 1. Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Review 2. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

3. NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression.

Review 4. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Review 5. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.

Review 6. Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications.

Review 7. Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism.

Review 8. Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors.

9. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.

Review 10. NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.